Methods for testing platelet function for transfusion medicine

Vox Sanguinis

Volumn 101, Issue 1, 2011, Pages 1-9

  Panzer, S ^a   Jilma, P ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

In vitro and in vivo function; Methods; Platelet concentrates; Platelet function

Indexed keywords

ABXICIMAB; ACETYLSALICYLIC ACID; BIOLOGICAL MARKER; LYSOSOME ASSOCIATED MEMBRANE PROTEIN; MONOCLONAL ANTIBODY; PADGEM PROTEIN; PHOSPHATIDYLSERINE; THROMBIN RECEPTOR ACTIVATING PEPTIDE 6; THROMBOCYTE CONCENTRATE; THROMBOSPONDIN 1; UNCLASSIFIED DRUG;

APHERESIS; APOPTOSIS; BLEEDING DISORDER; BLEEDING TIME; BLOOD ANALYSIS; BLOOD CLOTTING; BLOOD DONOR; BLOOD EXAMINATION; DIAGNOSTIC TEST ACCURACY STUDY; FIBRIN FORMATION; FLOW CYTOMETRY; GOLD STANDARD; HIGH SHEAR ASSAY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INTERMETHOD COMPARISON; LIGHT INTENSITY; LIGHT TRANSMISSION AGGREGOMETRY; LYSOSOME; MULTIPLE ELECTRODE AGGREGOMETRY; PHOTON CORRELATION SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SCREENING TEST; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION; THROMBOCYTE PRESERVATION; THROMBOCYTE TRANSFUSION; THROMBOELASTOGRAPHY; VON WILLEBRAND DISEASE;

BLEEDING TIME; BLOOD PLATELETS; ELECTRODES; EQUIPMENT FAILURE ANALYSIS; FLOW CYTOMETRY; HEMOSTASIS; HUMANS; PLATELET COUNT; PLATELET FUNCTION TESTS; PLATELET TRANSFUSION; THROMBELASTOGRAPHY;

EID: 79958783037     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/j.1423-0410.2011.01467.x     Document Type: Review

References (75)

1. Jurk K, Kehrel BE: Pathophysiology and biochemistry of platelets. Internist 2010; 51:1086-1094
2. Ay C, Jungbauer LV, Sailer T, et al.: High concentrations of soluble P-selectin are associated with risk of venous thromboembolism and the P-selectin Thr715 variant. Clin Chem 2007; 53:1235-1243
3. Samir Hamaia, Chengyao Li, Jean-Pierre Allain: The dynamics of hepatitis C virus binding to platelets and 2 mononuclear cell lines. Blood 2001; 98:2293-2300
4. Weyrich AS, Lindemann S, Zimmerman GA: The evolving role of platelets in inflammation. J Thromb Haemost 2003; 1:1897-1905
5. Smyth SS, McEver RP, Weyrich AS, et al.: Platelet colloquium participants. Platelet functions beyond hemostasis. J Thromb Haemost 2009; 7:1759-1766
6. Cardigan R, Turner C, Harrison P: Current methods of assessing platelet function: relevance to transfusion medicine. Vox Sang 2005; 88:153-163
7. Rinder HM, Ault KA: Platelet activation and its detection during the preparation of platelets for transfusion. Trans Med Rev 1998; 12:271-287
8. Duke WW: The relation of blood platelets to hemorrhagic disease. Description of a method for determining the bleeding time and the coagulation time and report of three cases of hemorrhagic disease relieved by blood transfusion. JAMA 1910; 55:1185-1192
9. Nilsson IM, Magnusson S, Borchgrevink C: The Duke and Ivy methods for determination of the bleeding time. Thromb Diath Haemorrh 1963; 10:223-234
10. Mielke CH Jr, Kaneshiro MM, Maher IA, et al.: The standardized normal Ivy bleeding time and its prolongation by aspirin. Blood 1969; 34:204-215
11. Harker LA, Slichter SJ: The bleeding time as a screening test for evaluation of platelet function. N Engl J Med 1972; 287:155-159
12. Slichter SJ, Raife TJ, Davis K, et al.: Platelets photochemically treated with amotosalen HCl and ultraviolet A light correct prolonged bleeding times in patients with thrombocytopenia. Transfusion 2006; 46:731-740
13. Born GV: Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 1962; 194:927-929
14. O'Brien JM: Platelet aggregation. II. Some results from a new method of study. J Clin Pathol 1962; 15:452-481
15. Murphy S, Gardner FH: Platelet storage at 22 degrees C; metabolic, morphologic, and functional studies. J Clin Invest 1971; 50:370-377
16. Rock G, Senack E, Tittley P: 5-day storage of platelets collected on a blood cell separator. Transfusion 1989; 29:626-628
17. Murphy S, Rebulla P, Bertolini F, et al.: In vitro assessment of the quality of stored PC. The BEST (Biomedical Excellence for Safer Transfusion) Task Force of the International Society of Blood Transfusion. Transfus Med Rev 1994; 8:29-36
18. Jilma-Stohlawetz P, Eichelberger B, Horvath M, et al.: In vitro platelet function of PC prepared using three different apheresis devices determined by impedance and optical aggregometry. Transfusion 2009; 49:1564-1568
19. Hagberg IA, Akkok CA, Lyberg T, et al.: Apheresis-induced platelet activation:comparison of three types of cell separators. Transfusion 2000; 40:182-192
20. Picker SM, Schneider V, Gathof BS: Platelet function assessed by shear-induced deposition of split triple-dose apheresis concentrates treated with pathogen reduction technologies. Transfusion 2009; 49:1224-1232
21. Rock G, Neurath D, Cober N, et al.: Seven-day storage of random donor PLT concentrates. Transfusion 2003; 43:1374-1377
22. Apelseth TØ, Bruserud Ø, Wentzel-Larsen T, et al.: In vitro evaluation of metabolic changes and residual platelet responsiveness in photochemical treated and gamma-irradiated single-donor platelet concentrates during long-term storage. Transfusion 2007; 47:653-665
23. Panzer S, Höcker L, Koren D: Agonists-induced platelet activation varies considerably in healthy male individuals: studies by flow cytometry. Ann Hematol 2006; 85:121-125
24. Panzer S, Höcker L, Rieger M, et al.: Agonist-inducible platelet activation in chronic idiopathic autoimmune thrombocytopenia. Eur J Haematol 2007; 79:198-204
25. Stohlawetz P, Horvath M, Pernerstorfer T, et al.: Effects of nitric oxide on platelet activation during plateletpheresis and in vivo tracking of biotinylated platelets in humans. Transfusion 1999; 39:506-514
26. Rinder HM, Murphy M, Mitchell JG: Progressive platelet activation with storage: evidence for shortened survival of activated platelets after transfusion. Transfusion 1991; 31:409-414
27. Triulzi DJ, Kickler TS, Braine HG: Detection and significance of alpha granule membrane protein 140 expression on platelets collected by apheresis. Transfusion 1992; 32:529-533
28. Dumont LJ, AuBuchon JP, Whitley P.: Seven-day storage of single-donor platelets: recovery and survival in an autologous transfusion study. Transfusion 2002; 42:847-854
29. Berger G, Hartwell DW, Wagner DD: P-Selectin and platelet clearance. Blood 1998; 11:4446-4452
30. Michelson AD: Flow cytometric analysis of platelets. Vox Sang 2000; 78(Suppl 2):137-142
31. Leytin V, Allen DJ, Gwozdz A, et al.: Role of platelet surface glycoprotein Ibalpha and P-selectin in the clearance of transfused platelet concentrates. Transfusion 2004; 44:1487-1495
32. Goodrich RP, Li J, Pieters H, et al.: Correlation of in vitro platelet quality measurements with in vivo platelet viability in human subjects. Vox Sang 2006; 90:279-285
33. Skripchenko A, Kurtz J, Moroff G, et al.: Platelet products prepared by different methods of sedimentation undergo platelet activation differently during storage. Transfusion 2008; 48:1469-1477
34. Tynngård N, Lindahl TL, Trinks M, et al.: The quality of platelet concentrates produced by COBE Spectra and Trima Accel cell separators during storage for 7days as assessed by in vitro methods. Transfusion 2008; 48:715-722
35. Dijkstra-Tiekstra MJ, Pietersz RN, Huijgens PC: Correlation between the extent of platelet activation in platelet concentrates and in vitro and in vivo parameters. Vox Sang 2004; 87:257-263
36. Gutensohn K, Alisch A, Crespeigne N, et al.: Biocompatibility of a new cell separator studied by flow cytometry: analyses of platelet antigens during apheresis and storage. Transfusion 1999; 39:742-747
37. Jilma-Stohlawetz P, Horvath M, Eichelberger B, et al.: Platelet function under high-shear conditions from platelet concentrates. Transfusion 2008; 48:129-135
38. Sandgren P, Callaert M, Shanwell A, et al.: Storage of platelet concentrates from pooled buffy coats made of fresh and overnight-stored whole blood processed on the novel Atreus 2C+ system: in vitro study. Transfusion 2008; 48:688-696
39. Diedrich B, Sandgren P, Jansson B, et al.: In vitro and in vivo effects of potassium and magnesium on storage up to 7days of apheresis platelet concentrates in platelet additive solution. Vox Sang 2008; 94:96-102
40. Metzelaar MJ, Korteweg J, Sixma JJ, et al.: Comparison of platelet membrane markers for the detection of platelet activation in vitro and during platelet storage and cardiopulmonary bypass surgery. J Lab Clin Med 1993; 121:579-587
41. Canault M, Duerschmied D, Brill A, et al.: p38 mitogen-activated protein kinase activation during platelet storage: consequences for platelet recovery and hemostatic function in vivo. Blood 2010; 115:1835-1842
42. Albanyan AM, Murphy MF, Rasmussen JT, et al.: Measurement of phosphatidylserine exposure during storage of platelet concentrates using the novel probe lactadherin: a comparison study with annexin V. Transfusion 2009; 49:99-107
43. Wittmann G, Romann A, Conell B., et al.: Functional quality control of platelet concentrates using multiple electrode aggregometry: 50th annual meeting of the Society of Thrombosis and Haemostasis Research 2006
44. Rahe-Meyer N, Winterhalter M, Boden A, et al.: Platelet concentrates transfusion in cardiac surgery and platelet function assessment by multiple electrode aggregometry. Acta Anaesthesiol Scand 2009; 53:168-175
45. Thromboelastography. Special issue dedicated to Professor Dr. Hellmut Hartert. Semin Thromb Hemost 1995; 21(Suppl 4):4 p preceding 1, 1-93
46. Gutensohn K, Geidel K, Kroeger N, et al.: Platelet function testing in apheresis products: flow cytometric, resonance thrombographic (RTG) and rotational thrombelastographic (roTEG) analyses. Transfus Apher Sci 2002; 26:147-155
47. Svendsen MS, Rojkjaer R, Kristensen AT, et al.: Impairment of the hemostatic potential of platelets during storage as evaluated by flow cytometry, thrombin generation, and thrombelastography under conditions promoting formation of coated platelets. Transfusion 2007; 47:2057-2065
48. Stiegler G, Fischer G, Ramanathan G, et al.: P-selectin mRNA is maintained in platelet concentrates stored at 4 degrees C. Transfusion 2009; 49:921-927
49. Murphy S, Gardner FH: Effect of storage temperature on maintenance of platelet viability-deleterious effect of refrigerated storage. N Engl J Med 1969; 280:1094-1098
50. Male C, Koren D, Eichelberger B, et al.: Monitoring survival and function of transfused platelets in Glanzmann thrombasthenia by flow cytometry and thrombelastography. Vox Sang 2006; 91:174-177
51. Kettner SC, Panzer OP, Kozek SA, et al.: Use of abciximab-modified thrombelastography in patients undergoing cardiac surgery. Anesth Analg 1999; 89:580-584
52. Maurer-Spurej E, Labrie A, Pittendreigh C, et al.: Platelet quality measured with dynamic light scattering correlates with transfusion outcome in hematologic malignancies. Transfusion 2009; 49:2276-2284
53. Jilma B, Fuchs I: Detecting aspirin resistance with the platelet function analyzer (PFA-100). Am J Cardiol 2001; 88:1348-1349
54. Jilma B: Platelet function analyzer (PFA-100): a tool to quantify congenital or acquired platelet dysfunction. J Lab Clin Med 2001; 138:152-163
55. Borzini P, Lazzaro A, Mazzucco L: Evaluation of the hemostatic function of stored platelet concentrates using the platelet function analyzer (PFA-100). Haematologica 1999; 84:1104-1109
56. Beck KH: Quality control of platelets during storage by the PFA-100: a comparison to platelet aggregation. Transfus Apher Sci 2002; 27:247-253
57. Böck M, Rahrig S, Kunz D, et al.: Platelet concentrates derived from buffy coat and apheresis: biochemical and functional differences. Transfus Med 2002; 12:317-324
58. Jilma-Stohlawetz P, Hergovich N, Homoncik M, et al.: Impaired platelet function among platelet donors. Thromb Haemost 2001; 86:880-886
59. Harrison P, Segal H, Furtado C, et al.: High incidence of defective high-shear platelet function among platelet donors. Transfusion 2004; 44:764-770
60. Stuart MJ, Murphy S, Oski FA, et al.: Platelet function in recipients of platelets from donors ingesting aspirin. N Engl J Med 1972; 287:1105-1109
61. Eriksson L, Kristensen J, Olsson K, et al.: Evaluation of platelet function using the in vitro bleeding time and corrected count increment of transfused platelets. Comparison between platelet concentrates derived from pooled buffy coates and apheresis. Vox Sang 1996; 70:69-75
62. Salama ME, Raman S, Drew MJ, et al.: Platelet function testing to assess effectiveness of platelet transfusion therapy. Transfus Apher Sci 2004; 30:93-100
63. Hayward CP, Harrison P, Cattaneo M, et al.: Platelet Physiology Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis: Platelet function analyzer (PFA)-100 closure time in the evaluation of platelet disorders and platelet function. J Thromb Haemost 2006; 4:312-319
64. Savion N, Varon D: Impact-the cone and plate(let) analyzer: testing platelet function and anti-platelet drug response. Pathophysiol Haemost Thromb 2006; 35:83-88
65. Panzer S, Rieger M, Vormittag R, et al.: Platelet function to estimate the bleeding risk in autoimmune thrombocytopenia. Eur J Clin Invest 2007; 37:814-819
66. Morrison A, Hornsey VS, Prowse CV, et al.: Use of the DiaMed Impact R to test platelet function in stored platelet concentrates. Vox Sang 2007; 93:166-172
67. Albanyan AM, Murphy MF, Harrison P: Evaluation of the Impact-R for monitoring the platelet storage lesion. Platelets 2009; 20:1-6
68. Baumgartner HR.: The role of blood flow in platelet adhesion, fibrin deposition, and formation of mural thrombi. Microvasc Res 1973; 5:167-179
69. Lozano M, Galan A, Mazzara R, et al.: Leukoreduced buffy coat-derived platelet concentrates photochemically treated with amotosalen HCl and ultraviolet A light stored up to 7days: assessment of hemostatic function under flow conditions. Transfusion 2007; 47:666-671
70. Perez-Pujol S, Tonda R, Lozano M, et al.: Effects of a new pathogen-reduction technology (Mirasol PRT) on functional aspects of platelet concentrates. Transfusion 2005; 45:911-919
71. Panzer S, Eichelberger B, Koren D, et al.: Monitoring survival and function of transfused platelets in Bernard-Soulier syndrome by flow cytometry and a cone and plate(let) analyzer (Impact-R). Transfusion 2007; 47:103-106
72. Horvath M, Eichelberger B, Koren D, et al.: Function of platelets in apheresis platelet concentrates and in patient blood after transfusion as assessed by Impact-R. Transfusion 2010; 50:1036-1042
73. Diedrich B, Ringdén O, Watz E, et al.: A randomized study of buffy coat platelets in platelet additive solution stored 1-5 versus 6-7days prior to prophylactic transfusion of allogeneic haematopoietic progenitor cell transplant recipients. Vox Sang 2009; 97:254-259
74. Slichter SJ, Kaufman RM, Assmann SF, et al.: Dose of prophylactic platelet transfusions and prevention of hemorrhage. N Engl J Med 2010; 362:600-613
75. Rinder HM, Smith BR.: In vitro evaluation of stored platelets: is there hope for predicting posttransfusion platelet survival and function? Transfusion 2003; 43:2-6